Department of Pharmaceuticals Extends UCPMP Marketing Expense Submission Deadline for FY25, ETPharma

New Delhi: The Department of Pharmaceuticals has extended the time limit for disclosing marketing expenditure for FY25, under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) till August 31, 2025.

In a letter to the Industry representative bodies, including IPA, OPPI, IDMA and FICCI, the Department of Pharmaceuticals, Policy Division conveyed that the timeline for Self-declaration and disclosure of marketing expenditure for the financial year 2024-25 has been extended over a month till August 31, 2025.

Earlier, the notified deadline to make the required disclosures was July 31.

Under the UCPMP rules notified in 2024, pharmaceutical companies are required to disclose information about their marketing activities, particularly those involving interactions with healthcare professionals, promotional activities, and other interactions aimed at ensuring transparency and preventing unethical practices.

• Published On Aug 4, 2025 at 12:38 PM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

Get updates on your preferred social platform

Follow us for the latest news, insider access to events and more.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}